Internal Medicine · Addison, TX
NPI
1992852362
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
14131 Midway Rd, Suite 620
Addison, TX, 75001
Phone (972) 249-0200
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$262K
1,835 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Suhasini Atluri prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 141 prescriptions and refills. In total Suhasini Atluri wrote 1,835 Medicare prescriptions that cost $262K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Synthroid Levothyroxine Sodium | 141 | 141 | 18 | $1,701 |
| Esomeprazole Magnesium Generic | 121 | 121 | 16 | $31K |
| Atorvastatin Calcium Generic | 119 | 119 | 16 | $854 |
| Levetiracetam Generic | 94 | 94 | 12 | $5,560 |
| Omeprazole Generic | 67 | 67 | 11 | $474 |
| Lacosamide Generic | 55 | 55 | Under 11 | $4,278 |
| Dilantin Phenytoin | 48 | 48 | Under 11 | $1,939 |
| Phenobarbital Generic | 43 | 43 | Under 11 | $515 |
| Montelukast Sodium Generic | 42 | 42 | Under 11 | $529 |
| Metoclopramide Hcl Generic | 32 | 32 | Under 11 | $629 |
| Primidone Generic | 29 | 29 | Under 11 | $1,447 |
| Lisinopril Generic | 28 | 28 | Under 11 | $146 |
| Metformin Hcl Generic | 26 | 26 | Under 11 | $160 |
| Tamsulosin Hcl Generic | 24 | 24 | Under 11 | $372 |
| Rosuvastatin Calcium Generic | 24 | 24 | Under 11 | $245 |
Brand drugs: 347 claims; generic drugs: 1,445 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Suhasini Atluri were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.